Volume 1 · Issue 5

Neurodegeneration & the Aging Brain

From cognitive reserve to longitudinal biomarkers, this issue examines the progression of neurodegenerative conditions and the evidence used to distinguish aging from disease.

100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief

Issue 5 · Reading list

Explore the research

Download issue catalog

100 readings · Page 5 of 5

  1. Neurodegeneration biomarkers and longitudinal studies · CC BY 2.0

    Cognitive lifestyle jointly predicts longitudinal cognitive decline and mortality risk.

    Riccardo E Marioni, Cecile Proust-Lima, Helene Amieva, Carol Brayne et al.

    European journal of epidemiology · 2014

    Original article
  2. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Cerebral small vessel disease burden and longitudinal cognitive decline from age 73 to 82: the Lothian Birth Cohort 1936.

    O K L Hamilton, S R Cox, J A Okely, F Conte et al.

    Translational psychiatry · 2021

    Original article
  3. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Machine learning-based prediction of longitudinal cognitive decline in early Parkinson's disease using multimodal features.

    Hannes Almgren, Milton Camacho, Alexandru Hanganu, Mekale Kibreab et al.

    Scientific reports · 2023

    Original article
  4. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.

    Yi-He Chen, Rong-Rong Lin, Hui-Feng Huang, Yan-Yan Xue et al.

    Frontiers in aging neuroscience · 2022

    Original article
  5. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline.

    Neel H Mehta, Liangdong Zhou, Yi Li, Laura Beth McIntire et al.

    Scientific reports · 2023

    Original article
  6. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.

    Qingling Sun, Jingnian Ni, Mingqing Wei, Siwei Long et al.

    Frontiers in aging neuroscience · 2022

    Original article
  7. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum.

    Ming-Liang Wang, Qiao-Qiao Zou, Zheng Sun, Xiao-Er Wei et al.

    Alzheimer's research & therapy · 2022

    Original article
  8. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review.

    Karolina Wilczyńska, Napoleon Waszkiewicz

    Journal of clinical medicine · 2020

    Original article
  9. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    In pursuit of degenerative brain disease diagnosis: Dementia biomarkers detected by DNA aptamer-attached portable graphene biosensor.

    Tyler Andrew Bodily, Anirudh Ramanathan, Shanhong Wei, Abhijith Karkisaval et al.

    Proceedings of the National Academy of Sciences of the United States of America · 2023

    Original article
  10. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    The Triglyceride-Glucose Index Is Associated with Longitudinal Cognitive Decline in a Middle-Aged to Elderly Population: A Cohort Study.

    Siqi Li, Xuan Deng, Yumei Zhang

    Journal of clinical medicine · 2022

    Original article
  11. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation.

    Per Kristian Eide, Aslan Lashkarivand, Are Hugo Pripp, Lars Magnus Valnes et al.

    Brain communications · 2023

    Original article
  12. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome.

    Carla M Startin, Bryony Lowe, Sarah Hamburg, Rosalyn Hithersay et al.

    Frontiers in psychiatry · 2019

    Original article
  13. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Poor long-term outcomes and abnormal neurodegeneration biomarkers after military traumatic brain injury: the ADVANCE study.

    Neil Sn Graham, Grace Blissitt, Karl Zimmerman, Lydia Orton et al.

    Journal of neurology, neurosurgery, and psychiatry · 2025

    Original article
  14. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.

    Min-Koo Park, Jinhyun Ahn, Young-Ju Kim, Ji-Won Lee et al.

    Cells · 2024

    Original article
  15. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer's disease.

    Atul Kumar, Maryam Shoai, Sebastian Palmqvist, Erik Stomrud et al.

    Scientific reports · 2021

    Original article
  16. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Resting-state connectivity stratifies premanifest Huntington's disease by longitudinal cognitive decline rate.

    Pablo Polosecki, Eduardo Castro, Irina Rish, Dorian Pustina et al.

    Scientific reports · 2020

    Original article
  17. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition.

    Mattia Trunfio, Cristiana Atzori, Marta Pasquero, Alessandro Di Stefano et al.

    Viruses · 2022

    Original article
  18. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Dulaglutide and neurodegeneration biomarkers: REWIND post hoc analysis.

    Jonathan M Wilson, Jeffrey L Dage, Hui-Rong Qian, Courtney L Irelan et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

    Original article
  19. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Neurodegeneration Biomarkers in Epilepsy: A Critical Review of Current Findings.

    Ambra Butera, Simona D'Antoni, Antonio Gennaro Nicotera, Maria Vincenza Catania et al.

    Life (Basel, Switzerland) · 2026

    Original article
  20. Neurodegeneration biomarkers and longitudinal studies · CC BY 4.0

    Sleep and APOE-ε4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline in older adults.

    Xianfeng Yu, Xia Zhou, Zhengbo He, Beiqi He et al.

    CNS neuroscience & therapeutics · 2024

    Original article